Unity Biotechnology’s investigational eye treatment failed to match Eylea at 20 weeks—part of the mid-stage trial’s primary ...
A significant percentage of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) demonstrate coronary artery calcification (CAC) on imaging, with variations by ANCA ...
Complete 36-week results from the ASPIRE study involving 52 patients are expected in the second quarter of 2025.
Rheumatologists and cardiologists have long co-managed patients out of necessity and without much formal collaboration or ...
A new systematic review explores AI’s role in vasculitis diagnosis, highlighting its accuracy in Kawasaki disease and potential for predictive analytics.
These signs pointed to a severe autoimmune kidney disorder known as Pauci-immune Crescentic Glomerulonephritis, a rare ...
HC Wainwright reissued their buy rating on shares of InflaRx (NASDAQ:IFRX – Free Report) in a report issued on Friday morning ...
Envestnet Portfolio Solutions Inc. increased its stake in shares of argenx SE (NASDAQ:ARGX – Free Report) by 7.9% in the 4th quarter, Holdings Channel reports. The firm owned 1,509 shares of the ...
Patients receiving ICIs were associated with a greater risk of developing RA, but lower risks for SLE and SSc.
Peripheral Aneurysms and Artery Disorders: Some vascular diseases, like fibromuscular dysplasia, are much more common in ...
Background Since the publication of the European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis (LVV ... of antiplatelet or anticoagulant therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results